Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 319,000 | 587,000 | 217,000 | 207,000 | 267,000 |
| Receivables | 1,275,000 | 1,183,000 | 1,307,000 | 1,217,000 | 1,246,000 |
| Inventories | 1,016,000 | 946,000 | 897,000 | 884,000 | 931,000 |
| Income taxes - deferred | 496,000 | 447,000 | 288,000 | 433,000 | 458,000 |
| Other current assets | 365,000 | 443,000 | 302,000 | 0 | 0 |
| TOTAL | $3,471,000 | $3,606,000 | $3,011,000 | $3,022,000 | $3,105,000 |
| Non-Current Assets | |||||
| PPE Net | 1,490,000 | 1,507,000 | 1,546,000 | 1,564,000 | 1,670,000 |
| Intangibles | 12,667,000 | 11,504,000 | 11,643,000 | 12,262,000 | 16,234,000 |
| Other Non-Current Assets | 505,000 | 407,000 | 371,000 | 306,000 | 281,000 |
| TOTAL | $14,662,000 | $13,418,000 | $13,560,000 | $14,132,000 | $18,185,000 |
| Total Assets | $18,133,000 | $17,024,000 | $16,571,000 | $17,154,000 | $21,290,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 403,000 | 3,000 | 4,000 | 4,000 |
| Accounts payable and accrued liabilities | 209,000 | 262,000 | 246,000 | 232,000 | 203,000 |
| Accrued Expenses | 1,970,000 | 1,950,000 | 1,348,000 | 1,284,000 | 1,327,000 |
| Other current liabilities | 248,000 | 231,000 | 227,000 | 252,000 | 273,000 |
| TOTAL | $2,430,000 | $2,846,000 | $1,824,000 | $1,772,000 | $1,807,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,674,000 | 3,841,000 | 4,237,000 | 4,252,000 | 4,257,000 |
| Other Non-Current Liabilities | 2,974,000 | 2,666,000 | 2,569,000 | 2,547,000 | 2,008,000 |
| TOTAL | $9,383,000 | $7,721,000 | $8,208,000 | $8,512,000 | $8,130,000 |
| Total Liabilities | $11,813,000 | $10,567,000 | $10,032,000 | $10,284,000 | $9,937,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,348,346 | 1,330,512 | 1,324,193 | 1,357,426 | 1,451,346 |
| Common Shares | 16,000 | 16,000 | 16,000 | 15,000 | 15,000 |
| Retained earnings | -8,927,000 | -8,689,000 | -8,570,000 | -8,449,000 | -4,381,000 |
| Other shareholders' equity | 88,000 | 144,000 | 106,000 | -33,000 | -138,000 |
| TOTAL | $6,320,000 | $6,457,000 | $6,539,000 | $6,870,000 | $11,353,000 |
| Total Liabilities And Equity | $18,133,000 | $17,024,000 | $16,571,000 | $17,154,000 | $21,290,000 |